-
Taxonomy & unit
-
dei: USD
-
Description
-
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
-
Summary
-
RVL Pharmaceuticals plc quarterly Entity Public Float history and growth rate from Q3 2018 to Q2 2022.
- RVL Pharmaceuticals plc Entity Public Float for the quarter ending June 30, 2022 was $44.9M, a 27% decline year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Growth (%)